NBS1 variant I171V and breast cancer risk
Authors:
- 30 November 2007
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 112 (1) , 75-79
Abstract
The NBS1/p95 protein has a pivotal role in the sensing and repair of chromosome breaks. A missense mutation in the NBS1 gene, I171V, has recently been associated with a ninefold increased risk of breast cancer in Polish patients. Positive associations have also been reported for leukaemia and larynx cancer suggesting that I171V could be a more general susceptibility factor for malignancies. We investigated the prevalence of this mutation in two large hospital-based case-control series from Germany and from the Republic of Belarus. The I171V substitution was detected in 20/1,636 Byelorussian breast cancer patients and in 18/1,014 Byelorussian controls (OR: 0.68; 95%CI: 0.36–1.30, P = 0.3). The I171V substitution was furthermore detected in 10/1,048 German breast cancer patients and in 7/1,017 German controls (OR: 1.39; 95%CI: 0.53–3.67, P = 0.7). There were no significant differences between I171V carriers and non-carriers among the cases with regard to age at diagnosis, family history or bilateral occurrence of disease. A meta-analysis of all hitherto available studies did not reveal a difference in the prevalence of I171V between breast cancer cases and controls (OR: 1.05; 95%CI: 0.64–1.74, P = 0.9). We conclude that the I171V substitution is unlikely to constitute a strong risk factor for breast cancer in our study populations.Keywords
This publication has 27 references indexed in Scilit:
- Dual role of Nbs1 in the ataxia telangiectasia mutated‐dependent DNA damage responseThe FEBS Journal, 2006
- Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damageNature, 2005
- Nijmegen breakage syndrome: clinical manifestation of defective response to DNA double-strand breaksDNA Repair, 2004
- NBS1 and its functional role in the DNA damage responseDNA Repair, 2004
- Increased cancer risk of heterozygotes with NBS1 germline mutations in polandInternational Journal of Cancer, 2004
- Germline 657del5 mutation in the NBS1 gene in breast cancer patientsInternational Journal of Cancer, 2003
- Clinical ascertainment of Nijmegen breakage syndrome (NBS) and prevalence of the major mutation, 657del5, in three Slav populationsEuropean Journal of Human Genetics, 2000
- Nibrin, a Novel DNA Double-Strand Break Repair Protein, Is Mutated in Nijmegen Breakage SyndromeCell, 1998
- Nijmegen breakage syndrome.Journal of Medical Genetics, 1996
- An increased risk for malignant neoplasms in heterozygotes for a syndrome of microcephaly, normal intelligence, growth retardation, remarkable facies, immunodeficiency and chromosomal instabilityMutation Research/Reviews in Genetic Toxicology, 1990